Dubai, UAE: A new immersive healthcare app will be unveiled at Arab Health tomorrow. The ‘Roomi’ app, produced by Primer VR and sponsored by Symed (a Pharmatrade company), is designed to comfort, educate and reassure injured children aged between 6-12 years that are awaiting treatment for broken bones or muscular damage.
Combining the use of VR in hospitals and doctors’ clinics, with an at-home AR app for continued recovery, Roomi and friends provide an engaging and relatable way to inform young patients about upcoming procedures to help to reduce their fears and anxiety. Roomi’s story design, animation, and overall immersive experience have been custom built and are medically vetted to aid young patients in the healing process, relying on empathic characters and accurate information, portrayed in a vivid immersive world. This content approach is a first-of-a-kind, creating pediatric edutainment supported by original characters, targeting specific procedures.
The Primer VR roadmap for Roomi includes expanding the immersive technology through trials and clinical study. The company is committed to crafting immersive healthcare content that harnesses the power of VR and AR to alleviate pediatric patient anxiety, as well as educating children about upcoming procedures and existing conditions. Further, the platform is being developed to encourage improved recoveries through an engaging AR portal, which patients can use at home while they heal. The entire 'Roomi-verse' is designed to be playful and language agnostic, offering a calm and inviting atmosphere appealing to a broad global market.
Roomi is the latest example of virtual and augmented reality being applied to the medical industry. Renowned institutions including Cedars-Sinai Medical Center, Children’s Hospital Los Angeles, and St. Jude Children’s Research Hospital have all embraced immersive technology as a valuable tool for patient-facing therapeutic, educational, and entertainment purposes.
The app is the first of several upcoming immersive projects for Primer VR. For more information, you can visit Primer VR at Arab Health 2020, booth PZ.F30 or online at: www.primervr.com
-Ends-
For media enquiries, please contact Samantha Dancy, Footstep Communications, on +971 55 5711006
About Primer VR
Primer VR is a Los Angeles based company featuring a team with over twenty years of leading-edge entertainment and technology experience. Lead by award-winning filmmaker Elia Petridis, Primer VR brings together expert technologists, storytellers, animators and experience designers to create healthcare applications custom built to meet the needs of specific pediatric medical procedures and conditions.
Working with healthcare professionals, Primer VR’s mission is to advance how pediatric health outcomes are achieved. Roomi, Primer VR's first initiative, which blends both virtual and augmented reality, will ultimately expand into the ‘Roomi-verse,’ becoming a broad medical VR and AR educational and therapy platform.
About Symed
Symed is a Pharmatrade company and proud sponsor of Roomi. Pharmatrade Group of Companies are renowned for healthcare innovation while being a preeminent distributor of medical, laboratory, and pharmaceutical products in the UAE.
Since 2002, Symed has been serving the medical community in the UAE with equipment and services from major worldwide manufacturers, including: GE Healthcare Ultrasound and Bone Densitometry Equipment, ArjoHuntleigh Patient Handling and Hygiene Solutions, and Waldmann UV Treatment and Diagnostic Systems
Symed believes in the power of providing technologically advanced healthcare applications that positively impact healthcare outcomes.
© Press Release 2020Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
